Home
overview

For the latest COVID-19 Travel restrictions and recommendations please click here

SAE Media Group’s 3rd Annual Conference
Pre-Filled Syringes San Francisco
September 19 - 20, 2022 | San Francisco, CA, USA
-------------------------------------------------------------------------

The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.

This year’s conference will be assessing the latest developments in new technologies for next generation device design, including computational simulation approaches forming the digital revolution of devices design. Furthermore, the latest advances in digital combination product development will be explored through the lens of lifecycle management and user-centric combination products. Leading experts from big pharma will be presenting case studies on recent advances in platform approaches in drug delivery devices and smart devices, while a panel discussion will explore the emerging opportunities of platforms for injectable devices. With recent developments in industry regulations and guidance, the 2022 agenda will give an international insight into the global regulatory environment and leading FDA representatives will address the key standards to be aware of in injectable device development.
 

Over recent years we have seen the need for injectable devices to adapt to novel therapeutics. Our expert industry thought leaders will present case studies and updates to the industry’s approach to injectable delivery for novel drug products. Furthermore, our speakers will be assessing the key considerations for primary packaging and CMC approaches to injectable device development.
 

As part of SAE Media Group’s leading injectable drug delivery portfolio, this event is not to be missed.

The two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

We look forward to welcoming you to the conference in September 2022.
 

 

  • Delve into the latest technologies and digital revolution for drug delivery device design
  • Explore approaches to advanced platforms for combination products and injectable delivery
  • Engage in international insights to the pre-filled syringes landscape and harmonization
  • Hear from industry leaders on evolving injectable delivery devices for novel therapeutics
  • Assess developments in primary packaging and CMC considerations for injectable devices
     

 

  • Drug-delivery developers
  • Medical Device Engineers
  • Primary Packaging material designers
  • Secondary packagers
  • Smart device developers
  • Training device developers
  • Device-safety solution providers
  • Drug developers

Previous attendees include:

 

Alexion Pharmaceuticals; Almac Group; Amgen; Amgen Inc; Amgen Inc.; Amgen, Inc.; AnaptysBio; Ascendis Pharma; AstraZeneca; Biogen; Boston Analytical Inc; Coherus Biosciences; Corning Inc; Corning, Inc.; Eagle Pharmaceuticals; Eagle Pharmaceuticals, Inc.; Eli Lilly and Company; Genentech; Genentech, Inc.; Glenmark Pharmaceuticals Inc.; Janssen Pharmaceuticals; Janssen R&D; Jazz Pharmaceuticals; Johnson & Johnson; Johnson & Johnson - Janssen; Johnson & Johnson Research & Development; Merck; Merck & Co. Inc.; Minapharm Pharmaceuticals; Pfizer; Pfizer Inc.; Pfizer, Inc; Regeneron; Regeneron Pharmaceuticals; Regeneron Pharmaceuticals Inc; Regeneron Pharmaceuticals, Inc.; Sanofi Pasteur; Takeda; Takeda Pharmaceutical Company Limited; U.S. Food and Drug Administration; UserWise, Inc.; Zacros America, Inc.; Zeon Corporation; Zeon Specialty Materials ; Zeon Specialty Materials Inc;

Conference programme

8:00 Registration & Coffee

9:00 Chairs' Opening Remarks

Scott Nunn

Scott Nunn, Director, Device Development, Gilead Sciences

Renato Ravanello

Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
View Bio

9:10 The Transformational Role of Digital Revolution in Pharm & Medical Industries: A Quality Perspective

Alie Jahangir

Alie Jahangir, Sr. Principal Engineer, Product Quality Management, Janssen Pharmaceuticals
View Bio

  • Digital transformation will Improve efficiency and productivity by providing useful tools in predictive maintenance and product traceability.
  • Digital verification and validation ensure the accuracy and correctness of digital simulations and models and provides. 
  • Computational models and simulations will reduce time to market for new products, reduces costs at all stages of a product’s lifecycle, improve manufacturability with improved quality. 
  • Digital Transformation directly impacts patient safety and outcomes as well as product efficacy
  • 9:50 Lifecycle management for digital combination product development

    Abhi Raj

    Abhi Raj, Senior Director, Device Development, R&D, AstraZeneca

  • A look back on the past year and developments in connected combination products
  • Ensuring effective risk management for a successful digital combination product
  • Regulatory considerations for the implementation of digital components in device development
  • Opportunities for enhancements of current combination products through digital tools
  • 10:30 Morning Coffee

    11:00 Smart Device Platforms and evolving device delivery technologies

  • Combination product smart device platform
  • Challenges in developing a platform for connected devices and assessing if a platform approach can effectively cater to all users 
  • How to incorporate connectivity with the user in mind?
  • Real world examples of connected device platform and a future outlook of digital health for drug delivery devices
  • Renato Ravanello

    Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
    View Bio

    11:40 Leveraging Platforms for Combination Product Development

    Nicholas Mandala

    Nicholas Mandala, Senior Director, Medical Device and Combination Product Technology, Pfizer
    View Bio

  • Risk management for combination drug delivery portfolios
  • Quality management systems and quality system development
  • Design control documentation efficiencies
  • Clinical and Human Factors considerations and case studies
  • 12:20 Networking Lunch

    13:20 Flexible approaches to injectable delivery device platforms

  • Leveraging platforms to support safety and effectiveness with other active ingredients
  • Introducing modifications in a device platform to avoid challenge of a ‘one-size-fits-all’ approach
  • Planning for the future, attempting to avoid premature platform obsolescence.
  • Planning for platform extensions to improve and extend the life cycle of the platform
  • James Leamon

    James Leamon, Director of Biologics Device Development, Jazz Pharmaceuticals
    View Bio

    Alie Jahangir

    Alie Jahangir, Sr. Principal Engineer, Product Quality Management, Janssen Pharmaceuticals
    View Bio

    Jamie Tsung

    Jamie Tsung, Head of DP formulation, Alnylam Pharmaceuticals, Inc
    View Bio

    Michael Song

    Michael Song, Associate Director, Takeda
    View Bio

    14:00 Global regulatory landscape and harmonization of combination products

    Peter Dorski

    Peter Dorski, Associate Director, CMC Regulatory Affairs, Janssen, Pharmaceutical Companies of Johnson and Johnson
    View Bio

  • Recent updates to international regulatory requirements for injectable combination products
  • Industry challenges in the evolving regulatory landscape
  • Assessing international harmonization: guidance for industry to conform to international standards
  • What we can expect in future updates to combination product international regulatory guidance and how to prepare
  • 14:40 Afternoon Tea

    15:10 Understanding the inconsistency in determining EPRs for injectable combination products

    Session Reserved For Biophorum

    Session Reserved For Biophorum, ,

  • The industry does not have a consensus view on how to apply EPRs guidance
  • BioPhorum collaboration has brought together experts to share their experiences on applying EPRs to injectable combination products
  • The team had created a set of matrices that highlight the differences in opinion for several injectable devices (including PFS)
  • 15:50 Chairs' Closing Remarks and Close of Day One

    Scott Nunn

    Scott Nunn, Director, Device Development, Gilead Sciences

    Renato Ravanello

    Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
    View Bio

    8:30 Registration & Coffee

    9:00 Chairs' Opening Remarks

    Scott Nunn

    Scott Nunn, Director, Device Development, Gilead Sciences

    Renato Ravanello

    Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
    View Bio

    9:10 An update on combination product and injection device regulatory guidance

    Alan M Stevens

    Alan M Stevens, Assistant Director, Injections Devices Team, U.S. Food and Drug Administration
    View Bio

  • A review of current guidance for pre-filled syringes and what is new from the past year
  • Updates to regulatory guidance on bridging studies for injectable devices
  • Essential performance requirements for combination products and injectable devices
  • Post market safety reporting for combination products
  • 9:50 Findings and Implications of U.S FDA-UserWise Training Decay Research

    Shannon Clark

    Shannon Clark, CEO, UserWise, Inc.
    View Bio

  • An overview of Training Decay and why it matters
  • What does the FDA say about Training Decay
  • Insights and revelations from our FDA-backed training decay research study
  • How our findings affect future regulatory policy
  • 10:30 Morning Coffee

    11:00 Device Development for Long Acting Injectables

    Scott Nunn

    Scott Nunn, Director, Device Development, Gilead Sciences

  • How have long-acting injectable devices evolved in recent years
  • Common pitfalls and challenges in long-acting combination product design
  • 11:40 Large volume Injectable Delivery of Biologics

    James Leamon

    James Leamon, Director of Biologics Device Development, Jazz Pharmaceuticals
    View Bio

  • The growing need for large volume delivery for biologics 
  • Challenges in delivery technology for biologics and what injectable devices are currently being used?
  • Overcoming formulation challenges for biologic delivery
  • How do we need the delivery system landscape to move forward meet the needs of biologic subcutaneous delivery?
  • 12:20 Networking Lunch

    13:20 Challenges and opportunities for high volume sub-cutaneous drug delivery

  • Opportunities to improve patient experience.
  • Device technology challenges.
  • Tolerability and other unknowns
  • Renato Ravanello

    Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
    View Bio

    14:00 Prefilled Syringe and Autoinjector Integration

    Weina Lu

    Weina Lu, Device Engineer, Dosage Form Design and Development, AstraZeneca
    View Bio

  • Background and Driver 
  • Key syringe dimensions contributing to the compatibility between prefilled syringe and autoinjector
  • Key areas to evaluate further
  • Essential performance requirements 
  • Glass breakage 
  • Device assembly
  • 14:40 Afternoon Tea

    15:10 Packaging and device development for a high viscosity long acting injectable

    Robert Ovadia

    Robert Ovadia, Senior Manager, Device Development and Clinical, Gilead Sciences
    View Bio

  • Development of a custom primary container for use with the high viscosity drug product
  • Characterization on the compatibility between the primary container and the drug product
  • Functionality testing on the primary container
  • 15:50 From early to late-stage development: Transitioning from vial to pre-filled syringe

    Session Reserved

    Session Reserved, ,

  • Approaches to pre-filled syringe development
  • Evaluating key CMC considerations
  • Challenges in transitioning from vial to pre-filled syringe and pathways to overcome these
  • 16:30 Chairs' Closing Remarks and Close of Day Two

    Scott Nunn

    Scott Nunn, Director, Device Development, Gilead Sciences

    Renato Ravanello

    Renato Ravanello, Sr. Director, Device and Packaging Development, Genentech
    View Bio

    +

    FEATURED SPEAKERS

    Abhi Raj

    Abhi Raj

    Senior Director, Device Development, R&D, AstraZeneca
    Alan M Stevens

    Alan M Stevens

    Assistant Director, Injections Devices Team, U.S. Food and Drug Administration
    Alie Jahangir

    Alie Jahangir

    Sr. Principal Engineer, Product Quality Management, Janssen Pharmaceuticals
    Denise Forkey

    Denise Forkey

    Director, Human Factors, UserWise, Inc.
    James Leamon

    James Leamon

    Director of Biologics Device Development, Jazz Pharmaceuticals
    Jamie Tsung

    Jamie Tsung

    Head of DP formulation, Alnylam Pharmaceuticals, Inc
    Nicholas Mandala

    Nicholas Mandala

    Senior Director, Medical Device and Combination Product Technology, Pfizer
    Peter Dorski

    Peter Dorski

    Associate Director, CMC Regulatory Affairs, Janssen, Pharmaceutical Companies of Johnson and Johnson
    Renato Ravanello

    Renato Ravanello

    Sr. Director, Device and Packaging Development, Genentech
    Robert Ovadia

    Robert Ovadia

    Senior Manager, Device Development and Clinical, Gilead Sciences
    Scott Nunn

    Scott Nunn

    Director, Device Development, Gilead Sciences
    Shannon Clark

    Shannon Clark

    CEO, UserWise, Inc.
    Weina Lu

    Weina Lu

    Device Engineer, Dosage Form Design and Development, AstraZeneca

    Abhi Raj

    Senior Director, Device Development, R&D, AstraZeneca
    Abhi Raj

    Alan M Stevens

    Assistant Director, Injections Devices Team, U.S. Food and Drug Administration
    Alan M Stevens

    CAPT Alan Stevens is the acting division director for the Division of Drug Delivery and General Hospital Devices and Human Factors, which includes the Injection Devices Team, Infusion Devices Team, General Hospital Devices Team, and the Human Factors and Reliability Engineering Team. This division regulates the product lifecycle of its devices, including premarket submission review and postmarket safety and compliance. The division also provides human factors expertise and consulting across FDA.
    Prior to becoming a manager in CDRH, CAPT Stevens spent 10 years as an engineering reviewer in the Office of Device Evaluation and three years as a compliance officer in CDRH’s Office of Compliance. CAPT Stevens received his undergraduate mechanical engineering degree and masters degree in reliability engineering from the University of Maryland.

    Alie Jahangir

    Sr. Principal Engineer, Product Quality Management, Janssen Pharmaceuticals
    Alie Jahangir

    Dr Jahangir is an innovative, and cross functional team leader at Janssen Pharmaceutical with a knowledge of complex global Quality trends and implementation of robust Quality Systems Management across Janssen various Biologic-Device Combination Products. He blends his multidisciplinary expertise in quality, R&D, and regulatory to guide and implement effective Quality System Management and leverages advanced digital technologies to impact current patient journey. Currently as a Sr. Principal engineer, his key areas of interest lie at the intersection of device quality system optimization and advanced digital tools with bold mission to encourage healthcare industries to revamp their existing digital infrastructure and excel in their data and digital science capabilities to address patients’ unmet needs device. Prior to Janssen, Alie has led a successful R&D career, managing, developing, and commercializing advanced polymeric technologies in consumer, oil & gas, and medical devices sectors. Dr. Jahangir is also an Adjunct Professor at the Department of Bioengineering at Temple University in Philadelphia. He holds a Doctorate and Master’s degree in Polymer & Biomedical Engineering from University of Toronto and Dalhousie University and completed a Post-Doctoral Fellowship at Harvard School of Public Health in Boston.

    Denise Forkey

    Director, Human Factors, UserWise, Inc.
    Denise Forkey

    Denise Forkey is currently Director, Human Factors at UserWise, a consultancy that helps medical device and combination product manufacturers and start-ups to design safe and easy-to-use medical products. She leads a team of human factors consultants who fulfil any and all aspects of the usability engineering process.

    Denise has experience performing use-related risk analyses, conducting usability testing, designing instructions for use and implementing the usability engineering process for home-use injection products through complex robotic surgery system. Denise regularly works on human factors submission strategy and compliance documentation for FDA Human Factors Guidance, and international standards related to usability engineering (e.g., IEC 62366-1, IEC 60601-1-6, and ISO 14971). She has helped numerous UserWise clients successfully navigate FDA human factors submissions, create usability documentation for CE mark, and manage notifying body and test lab audits of the usability engineering file. Denise has been working in the medical products industry for more than 25 years and has experience in medical device testing and quality systems/engineering, with her last 6 years focusing on human factors engineering processes and testing.

    She holds a master’s degree in Biomedical Engineering and has severed as a board member of the national Biomedical Engineering Society and the Bio2Device group and was the founding President of the San Francisco Bay Area Chapter of the Biomedical Engineering Society.

    James Leamon

    Director of Biologics Device Development, Jazz Pharmaceuticals
    James Leamon

    Jim is a medical device and drug device combination product development leader, an engineering director, and a manufacturing manager. He is experienced in working across functions and business groups in varying organizations. Jim has successfully brought new and effective products to market throughout the world and has developed and implemented new engineering, quality control and manufacturing processes. Jim continues to lead product development, and contract engineering teams while working at Jazz Pharmaceuticals. He is highly experienced and proficient in CMC drug-device combination product leadership as well as strategic planning, design engineering, manufacturing engineering and new product and process development. Currently, he is working with Jazz manufacturing teams to expand the availability of a current small cell lung cancer drug product that is in high demand.

    Jim is also a community leader in social justice and feeding the hungry. As treasurer of a non-profit organization, he has used his strategic planning and financial management skills to help people in need. This correlates well with his career drive to improve the lives of cancer patients and those with other life threatening diseases.

    Jamie Tsung

    Head of DP formulation, Alnylam Pharmaceuticals, Inc
    Jamie Tsung

    Dr. Jamie Tsung received her Ph.D. in pharmaceutical sciences from the University of Connecticut. Currently, she is an Associate Director at Alnylam Pharmaceuticals. Prior to Alnylam, she worked for Momenta, Shire, Baxter, and UCB. Her biopharmaceutical experience spans preclinical to marketed products, integrating formulation, characterization, processing technology, regulatory, and quality control providing a valuable perspective and creative approach to product development.

    Joyce Zhao

    Associate Director, Combination Product, Takeda
    Joyce Zhao

    Michael Song

    Associate Director, Takeda
    Michael Song

    Michael currently is Associate Director of Device Development at Takeda. Prior to his current role he was head of Combination Product Manufacturing at Heron Therapeutics where he led medical device and combination product commercial readiness. Prior to Heron, he formed and led the Device Functionality, Safety and Digital Connectivity group at AstraZeneca where his group oversaw device functionality portion of device development; primary container science and technology; biocompatibility; container closure integrity programs; and digital connectivity. Prior to AstraZeneca, he was head of Device, Package, and Process Engineering at Adello Biologics, a member of Amneal Pharmaceutical. He also has held key engineering lead and toxicology SME positions at Stryker, Kavlico, and other companies. Michael holds a BS in Electrical Engineering from Purdue University and PhD in Neuroscience and Toxicology from Iowa State University.

    Nicholas Mandala

    Senior Director, Medical Device and Combination Product Technology, Pfizer
    Nicholas Mandala

    Nick has spent more than 20 years in cross functional roles in the device and combination products industry including systems development, clinical manufacturing, manufacturing and process engineering, validation, and combination products quality assurance. He joined Pfizer in 2017 and currently leads the team responsible for lifecycle management of drug delivery devices, implantables, SaMDs, connected devices, and IVDs. His organization’s responsibilities include device strategy, design and development of medical devices and combination products, post market surveillance, and post market innovation and sustainability. He holds a B.S. in mechanical engineering from Cornell University.

    Peter Dorski

    Associate Director, CMC Regulatory Affairs, Janssen, Pharmaceutical Companies of Johnson and Johnson
    Peter Dorski

    Peter Dorski is an Associate Director, CMC Regulatory Affairs at Janssen, Pharmaceutical Companies of Johnson and Johnson. He has worked within the pharmaceutical and combination products industry for going on nine years, driving regulatory strategies based on industry best practices for global/major market product development and supporting advancement of complex, innovative delivery systems using leading-edge therapies.
    Within the pharma industry, Peter works to understand and influence the continuously evolving regulatory landscape surrounding combination products to serve industry stakeholders and patients. Peter holds a BS in microbiology from The Ohio State University and a MS in Health Sciences from The George Washington University.
     

    Renato Ravanello

    Sr. Director, Device and Packaging Development, Genentech
    Renato Ravanello

    Renato Ravanello is responsible for Late Stage Development in the Device and Packaging team at Genentech in South San Francisco, CA. Renato leads the design of new combinations products for clinical and commercial, focusing on new technologies for sub-cutaneous and ocular drug delivery.

    Renato has been developing and commercializing combination products and medical devices for over 17 years, and has extensive experience in pre-filled syringes, needle safety devices, injector pens, patch injectors, auto-injectors, ocular drug delivery, and respiratory and transdermal drug delivery devices. He holds an M.S. in Aerospace Engineering from the University of Colorado (Boulder) and a Degree in Aeronautical Engineering from the Politecnico di Milano (Italy).
     

    Robert Ovadia

    Senior Manager, Device Development and Clinical, Gilead Sciences
    Robert Ovadia

    Robert Ovadia joined Gilead in 2020 and leads a group responsible for primary container closure system development. He has a decade of industry experience and previously worked at Genentech in formulations and drug product process engineering. Robert graduated magna cum laude from the University of California, Davis with a BS in Biochemistry and Molecular Biology.

    Scott Nunn

    Director, Device Development, Gilead Sciences
    Scott Nunn

    Session Reserved

    ,
    Session Reserved

    Session Reserved For Biophorum

    ,
    Session Reserved For Biophorum

    Shannon Clark

    CEO, UserWise, Inc.
    Shannon Clark

    Shannon E. Clark is founder and CEO of UserWise, a consultancy that helps medical device manufacturers and start-ups to design safe and easy-to-use medical devices. The consultants at UserWise conduct usability testing for a variety of medical devices ranging from surgical robots to home-use injection platforms. UserWise consultants also perform safety assessments to comply with U.S. and international regulations related to Human Factors.

    Shannon graduated from UCLA with a B.S. in Mechanical Engineering and a technical breadth in Technology Management. Shannon is a Certified Professional Industrial Engineer, holds two patents, and has written and published three books.

    Weina Lu

    Device Engineer, Dosage Form Design and Development, AstraZeneca
    Weina Lu

    Weina Lu is a Device Engineer in the Dosage Form Design & Development group within Biopharmaceutical Department at AstraZeneca. She is the device technical lead and device responsible person for combination product development from the beginning till commercial launch in the parenteral biologic world.
    Weina received her Master’s degree in Mechanical Engineering from Worcester Polytechnic Institute. Prior to joining AstraZeneca, Weina worked at Massachusetts General Hospital, focusing on catheter-based optical medical device development.

    Sponsors

    Supporters

    Workshops

    Best Practices for Developing Effective Instructions for Combination Products
    Workshop

    Best Practices for Developing Effective Instructions for Combination Products

    Hyatt Centric Fisherman’s Wharf San Francisco
    21st September 2022
    San Francisco, USA

    VENUE

    Hyatt Centric Fisherman’s Wharf San Francisco

    555 North Point St, San Francisco, CA, USA

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SAE Media Group. SAE Media Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Workshop Agenda

    Download

    Speaker Bios

    Download

    Conference Co-Chair Letter

    Download

    Past Attendees

    Download

    SURVEY RESULTS INFOGRAPHIC - STATE OF THE INDUSTRY 2022

    Download

    Past Presentation - Paul Upham, Roche

    Download

    Past Presentation - Larry Atupem, ZEON

    Download

    Prefilled Syringes San Francisco Brochure 2022

    Download

    Sponsors


    Raumedic

    Sponsors
    http://www.raumedic.com

    Together with its customers, the medical technology company is breaking new ground to improve the diagnosis and treatment of diseases. In doing so, Raumedic focuses on polymer-based solutions for medical and pharmaceutical applications, as well as on products for intensive care. Raumedic has a global presence and a headcount of approximately 1,000. In its core markets of Europe and North America, the company manufactures using its own clean room production facilities.

    Media Partners


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Pharma Journalist

    Supporters
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    evvnt Ltd

    Supporters
    http://www.evvnt.com

    evvnt enables people all over the world to fill their events utilising the most effective event listing sites on the web. Every minute, with little more than a click, more events and conferences appear in listings, in search engines and on mobile - discoverable by both category and location. With next to no effort customers of evvnt get better attendance, while consumers find events they previously had no idea existed. To date customers in 70 countries worldwide have submitted over 500,000 thousand event listings, created over 300,000 live links, and generated 1 million clicks to ticketing and registration pages. Learn more at www.evvnt.com


    Gene Therapy Net

    Supporters
    http://www.genetherapynet.com

    Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines


    ONdrugDelivery Magazine

    Supporters
    http://ondrugdelivery.com

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Hyatt Centric Fisherman’s Wharf San Francisco

    555 North Point St
    San Francisco 94133
    USA

    Hyatt Centric Fisherman’s Wharf San Francisco

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out